Clinical trial

A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis

NCT00308282

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-03-28

PhasePHASE2

Study timeline

Study start (actual)2006-03-28Date precision: day

Registry last updated2019-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arthritis, Rheumatoidunresolved

Interventions

LY2127399DRUG

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

BucharestRomania1 Cluj-NapocaRomania1 IașiRomania1 TimișoaraRomania1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00308282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.